Explore Dr. David Andorsky's latest hematology and oncology research,...

155+
Accepted Abstracts & Presentations
75+
Co-Authors Across SCRI
55
Early Phase Studies Featured
75+
Sponsors Represented
20+
Research Sites Represented Through Selected Abstracts & Presentations
If you are member of the media who is interested in speaking with an expert from SCRI, please contact Becca Gelman at Becca.Gelman@SCRI.com.
We hope to see you in person at the 2025 ASCO® Annual Meeting. Join us for our “Meet the Expert” series at our Booth #27022, where colleagues and experts including physician leaders from across the SCRI network will be on site daily to answer your questions and share their knowledge. Check out the calendar!
Our accelerated operations model, Accelero maximizes all parts of SCRI to accelerate drug development and optimize clinical trial delivery. Coordinated through our CRO, SCRI Development Innovations, Accelero enhances connectivity to SCRI research sites, which in turn maximizes site contributions, optimizes site activation timelines, and synchronizes end-to-end clinical research management. Learn more.
Through our affiliated sites, our research network reaches one in five cancer patients, enrolling approximately 3,400 individuals in treatment trials each year.